|Articles|January 17, 2020
Clarivate to Acquire DRG
Advertisement
Clarivate Analytics plc has announced it has signed a definitive agreement to acquire Decision Resources Group. The $950 million purchase price, includes $900 million in cash and approximately $50 million in Clarivate ordinary shares to be issued following the one-year anniversary of closing.
For more details on this acquisition, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
3
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
4
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
5